---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-042714"
form_type: "8-K"
ticker: "NASC"
cik: "0001509957"
company_name: "Can B Corp"
filed_at: "2024-10-28T23:59:59+00:00"
generated_at: "2026-05-30T09:39:17.292638+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Can B Corp. completes holding company reorganization; becomes subsidiary of Nascent Pharma Holdings

## Summary
- On Oct 25, 2024, Can B merged with Nascent Merger Sub, becoming wholly owned subsidiary of Nascent Pharma Holdings.
- Each share of Can B stock automatically converted into an equivalent corresponding share of Nascent stock with same rights.
- Reorganization conducted under FBCA Section 607.11045 without stockholder vote; no gain/loss for tax purposes.
- Can B filed Form 15 to deregister its shares; Nascent becomes successor issuer under Exchange Act.
- Nascent assumed Can B's 2021 Incentive Stock Option Plan and all outstanding stock options, converted on same terms.

## SEC filing metadata
- accession: 0001493152-24-042714
- form_type: 8-K
- ticker: NASC
- cik: 0001509957
- company_name: Can B Corp
- filed_at: 2024-10-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 1.01, 3.01, 3.03, 5.03, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1509957/000149315224042714/0001493152-24-042714-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1509957/000149315224042714/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-042714
- JSON: https://secwatch.observer/filing/0001493152-24-042714.json
- Plain text: https://secwatch.observer/filing/0001493152-24-042714.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.